PT
PTC Therapeutics
PTCT · NASDAQ
$69.30 -1.87% (-$1.32)
1M -5.47%
Market Cap $5.96B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$76.3
10.1% upside
Trenutna cena
$69.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PTCT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
7 /100
Expensive P/S 5.91x
EV/EBITDA 32.31x
P/FFO N/A
Growth
100 /100
Growing Rev. growth 35.30%
FCF growth N/A
Book val. growth N/A
Profitability
34 /100
Moderate Net margin 3.80%
Op. margin 11.52%
FCF margin 32.97%
Quality
11 /100
Poor ROA 1.18%
Asset turnover 0.31x
ROIC 2.61%
Debt
74 /100
Low Int. coverage 0.64x
Net debt/EBITDA -2.04x
Current ratio 3.39x
Stability
25 /100
Unstable Rev. volatility 64.91%
EPS volatility 144.56%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PTCT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Klein
Employees
991
Headquarters
Warren
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report